Robert Rosenson is a Cardiology physician affiliated with Mount Sinai Health System. OpenAlex indexes 36 publications with 1,403 citations (h-index 15); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1190 5th Ave
New York, NY 100296503
Telephone
212-427-1540Provider last certified this registry record 5 Dec 2023.
Clinical trials
- The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease
Sponsor: Robert Rosenson
- Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes
Sponsor: Icahn School of Medicine at Mount Sinai
- Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
Sponsor: University of Michigan
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca UK LimitedProgram year20256 payments
- Eli Lilly and CompanyProgram year20252 payments
- Novo Nordisk IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
86.5%PCSK9 Inhibitor20.5%Repatha Sureclick72%Praluent Pen28%Part D≥85 patientsStatin16.8%Rosuvastatin Calcium71%Atorvastatin Calcium26%Pitavastatin Calcium4%Part D<11 patients+ 13 more classes in this area
Metabolism & gastrointestinal
10.7%GLP-1 receptor agonist6%Mounjaro69%Ozempic31%Part D<11 patientsSGLT2 inhibitor2.6%Jardiance100%Part D≥18 patients+ 2 more classes in this area
Blood & clotting
2.1%Factor Xa inhibitor1.5%Eliquis100%Part D<11 patientsP2Y12 inhibitor0.7%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2019–2022 per NIH RePORTER. The latest:
- Use of High Density Lipoprotein Proteome in the Prediction of Cognitive Impairment and Alzheimer's Disease: (REGARDS)
Icahn School of Medicine at Mount Sinai
FY2022$540,619R01AG061186 - Use of High Density Lipoprotein Proteome in the Prediction of Cognitive Impairment and Alzheimer's Disease: (REGARDS)
Icahn School of Medicine at Mount Sinai
FY2021$532,144R01AG061186 - Use of High Density Lipoprotein Proteome in the Prediction of Cognitive Impairment and Alzheimer's Disease: (REGARDS)
Icahn School of Medicine at Mount Sinai
FY2020$686,541R01AG061186
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- PALISADE: PLOZASIRAN DECREASES THE RISK OF ACUTE PANCREATITIS AND MAY IMPROVE QUALITY OF LIFE IN FAMILIAL CHYLOMICRONEMIA SYNDROME
American Journal of Preventive Cardiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Desnick, PhD, MD
Mount Sinai Health System
Mathew Williams, MD
Mount Sinai Health System
Ashutosh Tewari, MD
Mount Sinai Health System
Sahil Khera, MD, MPH
Mount Sinai Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”